Vifor Pharma to launch Probi products in Switzerland

Vifor Pharma to launch Probi products in Switzerland

Range will be sold under the Vitafor umbrella brand and Probi Digestis and Probi Defendum product brands.

Probi has signed a distribution and co-marketing agreement with Vifor Pharma, a company of the Galenica Group, to launch Probi’s gut and immune health products on the Swiss pharmacy and drugstore market. The range will be sold under the Vitafor umbrella brand and Probi Digestis and Probi Defendum product brands. The launch will take place in the fourth quarter of 2012 or the first quarter of 2013 and will be supported by strong consumer advertising and one of Switzerland’s best pharmacy sales forces.

Vifor Pharma is one of the most prominent consumer healthcare companies in the Swiss market and the cooperation between Probi and Vifor Pharma is an excellent opportunity to make a strong mark in the Swiss probiotics category.

”Probi and Vifor Pharma have already developed a close working relationship and the business model has many similarities with the successful collaboration between Probi and Bringwell in the Nordic markets. There is a significant market opportunity for premium probiotic dietary supplements in the Swiss market and we are very pleased to work with Vifor Pharma, one of the most professional consumer healthcare companies in Switzerland. The combination of the Vifor Pharma umbrella brand and the Probi product brands will be a strong proposition to pharmacies and consumers,” says Michael Oredsson, CEO at Probi.

Probi Digestis is based on Lactobacillus plantarum 299v, which targets bloating, gas formation and pain, symptoms that are very common today, sometimes mild or temporary but often more severe and diagnosed as IBS. Probi Defendum is based on the combination of two probiotic strains, Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2. It has been proven in large clinical studies to have beneficial effects on colds and cold symptoms.

“We consider Probi the partner of choice in probiotics due to its unique probiotic strains and the renowned strength of its science and clinical work. We are very pleased to have the opportunity to work with Probi in a partnership where both companies will contribute resources and expertise in their respective specialist fields,” comments Michele Borri, General Manager Vifor Pharma Consumer Healthcare Switzerland.


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.